Arkolith/Insider Trading/CMXC/Form 4

Jeffs David

Chief Executive Officer, Director, 10% OwnerCell MedX Corp. (CMXC) · full profile →Form 4 · filed Jan 10, 2024
Net Buying
Open-Market Buys
$150K
Open-Market Sells
$0
Net Open-Market Flow
$150K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 29, 2023Grant(A)74.0M$0.01$740K74.0M
Dec 29, 2023Buy(P)7.5M$0.01$75K81.5M
Dec 29, 2023Buy(P)7.5M$0.01$75K89.0M

Transaction Codes

A
Grant / award
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001626533-24-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML